Holen Sie sich die Stockscreener-App
12.06
1.95%
-0.24
Handel nachbörslich:
12.06
Schlusskurs vom Vortag:
$12.30
Offen:
$12.2
24-Stunden-Volumen:
1,359
Relative Volume:
0.09
Marktkapitalisierung:
$96.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.63%
1M Leistung:
+6.16%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$12.06
$12.40
1-Wochen-Bereich:
$10.91
$13.43
52-Wochen-Spanne:
$10.00
$13.43
Jatt Ii Acquisition Corp Stock (JATT) Company Profile
Firmenname
Jatt Ii Acquisition Corp
Sektor
Branche
Telefon
201-688-0364
Adresse
C/O APPLEBY GLOBAL SERVICES (CAYMAN) LTD, GEORGE TOWN
Compare JATT vs LION, XXI, UMAC, CCXI, DMII
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JATT
Jatt Ii Acquisition Corp
|
12.06 | 89.40M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.27 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.27 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
21.20 | 984.55M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
13.86 | 764.20M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.11 | 643.69M | 0 | 8.58M | -1.11M | 0.134 |
Jatt Ii Acquisition Corp Aktie (JATT) Neueste Nachrichten
FACT|FACT II Acquisition Corp|Price:10.660|Chg%:+0.010 - TradingKey
MACI|Melar Acquisition Corp I|Price:10.910|Chg%:+0.010 - TradingKey
SPEG|Silver Pegasus Acquisition Corp|Price:10.300| - TradingKey
JATT|JATT II Acquisition Ord Shs|Price:10.940|Chg%:-0.360 - TradingKey
Talawar Therapeutics Appoints Steve Migausky as Chief Legal and Administrative Officer - PR Newswire
Talawar Therapeutics - The Pharma Letter
Jatt Ventures Ii L.p. Net Worth (2026) - GuruFocus
Biotech-Focused Hedge Funds Back Talawar’s Fast Moving SPAC Merger - Institutional Investor
JATTJatt II Acquisition Corp Revenue Breakdown - Finviz
JATT II Acquisition (JATT) sponsor forfeits 225,000 shares after over-allotment expiry - Stock Titan
JATT II Acquisition Corp. (JATT) sponsor forfeits 225,000 Ordinary Shares - Stock Titan
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - AOL.com
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger - Yahoo Finance
Price to book forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar (NASDAQ: TLWR) to Merge with JATT II; $285M Expected - Stock Titan
Price to sales forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Price to earnings forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Talawar Therapeutics and JATT II Announce $285M Merger to Advance Bispecific Antibody for Atopic Dermatitis - Minichart
Talawar–JATT II deal includes $225M PIPE (NASDAQ: JATT) - Stock Titan
Biotech SPAC deal gets it to Nasdaq; AstraZeneca Phase 3 win in children's bone disease - Endpoints News
Talawar Tx launches as publicly traded biotech - The Pharma Letter
Enterprise value to revenue forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
Enterprise value to EBIT forward of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal - TradingView
Talawar, JATT II (Nasdaq: JATT) unveil $225M PIPE-backed biotech merger - Stock Titan
Talawar Therapeutics To Go Public Through A SPAC Deal With JATT II Acquisition - Pulse 2.0
JATT II Acquisition, Talawar Therapeutics announce combination agreement - TipRanks
Press Release: Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - Moomoo
Talawar Therapeutics Goes Public via SPAC with $285M to Advance Dual-Pathway Atopic Dermatitis Bispecific - BioPharm International
Talawar Tx Inc. entered into a definitive business combination agreement to acquire JATT II Acquisition Corp. from JATT Ventures II L.P. in a reverse merger transaction. - marketscreener.com
JATT II ACQUISITION CORP (JATT) Stock Chart - ChartMill
OCAC.U Stock Fund Price and Chart — BOATS:OCAC.U - TradingView
JATT Price Today: JATT II Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange
BermudaAppleby Advises Amanat Acquisition In Its USD75M Initial Public Offering - Mondaq
JATT II Acquisition Corp 2026 Q1 SEC Filing: Financials, Management Discussion, and Regulatory Disclosures - Minichart
JATT II Acquisition Corp. 1Q 2026: Net income $(68,793), EPS $(0.05) — 10-Q Summary - TradingView
JATT II Acquisition Corp (NASDAQ: JATT) files 10-Q after $60M SPAC IPO - Stock Titan
Cayman IslandsAppleby Advises JATT II Acquisition Corp In Its USD60M Initial Public Offering - Mondaq
Oaktree’s OACC SPAC Looks Quiet. The October Deadline Is the Real Story - Bez Kabli
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
Amanat Acquisition Corp Announces Pricing of $75 Million Initial Public Offering - Yahoo Finance
JATT II Acquisition Corp (JATT) Price To Free Cash Flow - Zacks Investment Research
GUACU|Berto Acquisition II Units (Proposed)|Price:10.065|Chg%:0.04 - TradingKey
JATT Acquisition (JATT) Stock Price, News & Analysis $JATT - MarketBeat
JATT Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of JATT II Acquisition Corp – NASDAQ:JATT - TradingView
JATT II Acquisition Corp (JATT) Price To Cash Flow - Zacks Investment Research
JATT II Acquisition (JATT) Stock Analysis Report | Financials & Insights - Benzinga
OTAI_u|OTAI_u.NB|Price:10.074|Chg%:0.02 - TradingKey
BWIV|Blue Water Acquisition IV Redeemable Units|Price:9.905|Chg%:-0.02 - TradingKey
SAGU_u|SAGU_u.NB|Price:10.080|Chg%:-0.03 - TradingKey
Finanzdaten der Jatt Ii Acquisition Corp-Aktie (JATT)
Es liegen keine Finanzdaten für Jatt Ii Acquisition Corp (JATT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):